What medications are appropriate for managing pain and facilitating passage of symptomatic kidney stones in adults?

Medications for Kidney Stones

For acute pain from kidney stones, use NSAIDs (diclofenac, ibuprofen, or metamizole) as first-line treatment, and for stone prevention, start with increased fluid intake to achieve 2 liters of urine daily, then add thiazide diuretics, potassium citrate, or allopurinol as monotherapy based on metabolic profile when conservative measures fail. 1

Acute Pain Management (Renal Colic)

NSAIDs are superior to opioids for acute renal colic pain control. 1, 2

• Use NSAIDs (diclofenac, ibuprofen, or metamizole) as first-line analgesics for acute kidney stone pain, as they reduce inflammation and lower pressure inside the urinary collecting system 1
• NSAIDs may reduce pain by approximately 3.84 cm on a 10 cm visual analog scale within 30 minutes compared to placebo 2
• NSAIDs reduce the need for additional rescue analgesia and cause less vomiting compared to opioids 1, 2, 3
• Reserve opioids (hydromorphine, pentazocine, or tramadol) as second-line agents only when NSAIDs are contraindicated or insufficient 1
• Avoid pethidine specifically due to high rates of vomiting and need for additional analgesia 1

Important Caveats for NSAIDs

• Use the lowest effective dose to minimize cardiovascular and gastrointestinal risks 1
• NSAIDs may impair renal function in patients with low glomerular filtration rate 1
• Monitor kidney function in at-risk patients 1

Medical Expulsive Therapy (MET) to Facilitate Stone Passage

Alpha-blockers (tamsulosin) may facilitate passage of distal ureteral stones >5 mm, though recent high-quality evidence shows conflicting results. 1

• Alpha-blockers are preferred over calcium channel blockers for MET, with 29% more patients passing stones compared to controls (95% CI: 20-37%) 1
• The greatest benefit appears to be for stones >5 mm in the distal ureter 1
• Nifedipine provides only marginal benefit (9% improvement, not statistically significant) 1

Critical Evidence Conflict

• However, a large 2018 randomized trial (SUSPEND) found no significant difference between tamsulosin and placebo for stones <9 mm (50% vs 47% passage rate, p=0.60) 4, 5
• An earlier 2009 meta-analysis showed benefit (RR 1.45), but this included smaller, lower-quality studies 6
• Given conflicting evidence, MET with alpha-blockers may be offered but should not be considered definitive therapy for all patients with ureteral stones 4, 5

Prevention of Recurrent Kidney Stones

First-Line: Non-Pharmacologic Management

All patients must increase fluid intake to achieve at least 2 liters of urine output per day. 1, 7, 8

• This reduces stone recurrence by approximately 55% (RR 0.45,95% CI 0.24-0.84) 7
• Spread fluid intake throughout the day rather than consuming large volumes at once 1
• No difference exists between tap water and mineral water 1, 8

Dietary modifications are essential: 1, 7

• Maintain normal dietary calcium intake of 1,000-1,200 mg daily—never restrict calcium, as restriction paradoxically increases urinary oxalate and stone risk 7, 9
• Limit sodium to ≤2,300 mg daily to reduce urinary calcium excretion 1, 7
• Reduce non-dairy animal protein to 5-7 servings weekly to decrease urinary calcium and uric acid 1, 7, 9
• Limit high-oxalate foods (nuts, chocolate, tea, spinach, wheat bran) particularly in patients with hyperoxaluria 1, 7
• Avoid sugar-sweetened beverages, especially colas acidified with phosphoric acid 1, 7, 8

Second-Line: Pharmacologic Monotherapy

When increased fluid intake fails to prevent recurrence, initiate pharmacologic monotherapy with one of three agents based on metabolic profile. 1, 7

Thiazide Diuretics (for High Urinary Calcium)

Offer thiazide diuretics to patients with high or relatively high urinary calcium and recurrent calcium stones. 1, 7

• Effective dosages include: 1
  • Hydrochlorothiazide 25 mg twice daily or 50 mg once daily
  • Chlorthalidone 25 mg once daily
  • Indapamide 2.5 mg once daily
• Reduces composite stone recurrence from 48.5% to 24.9% (RR 0.52,95% CI 0.39-0.69) 1, 7
• Continue dietary sodium restriction when prescribing thiazides to maximize hypocalciuric effect and limit potassium wasting 1
• Potassium supplementation (potassium citrate or chloride) may be needed 1
• Appropriate for both calcium oxalate and calcium phosphate stone formers 1

Potassium Citrate (for Low Urinary Citrate)

Offer potassium citrate to patients with recurrent calcium stones and low or relatively low urinary citrate. 1, 7

• Reduces composite stone recurrence from 52.3% to 11.1% (RR 0.25) 7
• Target urinary citrate >320 mg/day 7
• Citrate binds calcium and decreases urine acidity, inhibiting calcium phosphate crystallization 1
• Use potassium citrate, not sodium citrate, as sodium load increases urinary calcium excretion 1, 9
• Also effective for mixed uric acid and calcium oxalate stones, targeting urine pH 6.2-6.8 9

Allopurinol (for Hyperuricosuria)

Offer allopurinol to patients with recurrent calcium oxalate stones who have hyperuricosuria and normal urinary calcium. 1, 7

• Reduces composite stone recurrence from 55.4% to 33.3% (RR 0.59) 1, 7
• Indicated for hyperuricosuria (>800 mg/day in men, >750 mg/day in women) 9
• Typical dose: 200-300 mg daily 9
• Hyperuricemia is not required for allopurinol therapy 1
• Decreases uric acid in urine 1

Critical Treatment Principles

Do not use combination therapy as first-line treatment—monotherapy is equally effective with fewer adverse effects. 1, 7

• Combination therapy (thiazide + citrate or thiazide + allopurinol) offers no additional benefit over monotherapy 1, 7
• Adverse events are more common with pharmacologic therapies than dietary interventions 1
• Adverse events increase with combination therapy 7

Monitoring and Follow-Up

Obtain 24-hour urine collection to guide therapy selection and assess response. 7, 9

• Measure volume, pH, calcium, oxalate, uric acid, citrate, sodium, potassium, and creatinine 7, 9
• Repeat at 3-6 months after initiating therapy to assess response 7, 9
• Stone analysis should be performed for all first-time stone formers 1

Special Situations

Uric Acid Stones

Oral chemolysis with alkalinization is strongly recommended for uric acid stones. 1

• Use potassium citrate or sodium bicarbonate to achieve urine pH 7.0-7.2 1
• Patients should monitor urine pH and adjust medication accordingly 1
• Success rate of 80.5%, with 15.7% requiring further intervention 1

Cystine Stones

High fluid intake (≥4 liters daily) combined with sodium and protein restriction is essential. 1

• Target urinary cystine concentration <250 mg/L 1
• Limit sodium to ≤2,300 mg daily 1
• Limit animal protein intake 1

Sepsis or Anuria with Obstruction

Urgent decompression via percutaneous nephrostomy or ureteral stenting is mandatory. 1

• Delay definitive stone treatment until sepsis resolves 1
• Collect urine for culture before and after decompression 1
• Administer antibiotics immediately and adjust based on antibiogram 1

Common Pitfalls to Avoid

• Never restrict dietary calcium—this increases urinary oxalate and stone risk 7, 9
• Avoid calcium supplements unless specifically indicated; prefer dietary calcium consumed with meals to bind oxalate 7
• Do not use sodium-based alkali (sodium citrate/bicarbonate) instead of potassium citrate 1, 9
• Do not prescribe combination therapy as first-line—monotherapy is equally effective with fewer side effects 1, 7
• Avoid vitamin C supplements >1000 mg/day—vitamin C metabolizes to oxalate and increases stone risk 7
• Do not assume all alpha-blockers work for stone passage—recent high-quality evidence shows no benefit for stones <9 mm 4, 5